GCP
NAUT icon

GSA Capital Partners’s Nautilus Biotechnolgy NAUT Stock Holding History

GSA Capital Partners’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Sell
54,699
-69,352
-56% -$170K 0.01% 1430
2025
Q4 		$242K Sell
124,051
-135,152
-52% -$222K 0.02% 1293
2025
Q3 		$219K Buy
259,203
+82,295
+47% +$60.5K 0.02% 1382
2025
Q2 		$128K Buy
176,908
+164,396
+1,314% +$124K 0.01% 1593
2025
Q1 		$11K Buy
+12,512
New +$18.6K ﹤0.01% 1591
2023
Q1 		– Sell
-44,599
Closed -$80K – 1779
2022
Q4 		$80K Buy
44,599
+1,569
+4% +$3.03K 0.01% 1326
2022
Q3 		$91K Buy
+43,030
New +$108K 0.01% 1373

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GSA Capital Partners's NAUT Position: Q1 2026 in Review

GSA Capital Partners reduced its Nautilus Biotechnolgy (NAUT) stake by 56% in Q1 2026, selling an estimated $170K and leaving 54,699 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #1430.

GSA Capital Partners first reported a position in NAUT in Q3 2022 and has held it in 7 quarters since. The position peaked at $242K in Q4 2025. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • GSA Capital Partners held 54,699 shares of Nautilus Biotechnolgy worth $212K as of Q1 2026.
  • GSA Capital Partners sold 69,352 Nautilus Biotechnolgy shares in Q1 2026, an estimated $170K.
  • Nautilus Biotechnolgy made up 0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1430 holding.
  • GSA Capital Partners first reported a position in Nautilus Biotechnolgy in Q3 2022 and has held it in 7 quarters since.
  • GSA Capital Partners's Nautilus Biotechnolgy position peaked at $242K in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.